Due to an increase in the abuse of synthetic insulins, doping laboratories require faster and more consistent testing options. The methodology to detect and confirm the presence of peptide hormones by mass spectrometry is preferred to the current use of immunoassays or other immuno-reactive techniques. This white paper explores and compares the different available methods, revealing the fastest and most accurate options for synthetic insulin detection.

ASU researchers working in tech field that could one day help treat diseases including stroke, heart attacks, Parkinson's and arthritis.

Researchers at Case Western Reserve University School of Medicine have developed a method that could make magnetic resonance imaging-MRI-multicolor.

A new family of multichannel electronic pipettes is closing the gap between traditional manual pipettes and robotic systems. This new video will provide you with an informative insight into how to improve your biological sample processing and collection.

Diagnosing if a tick bite caused Lyme or another disease can be difficult but scientists are developing a new way to do it early - using a "signature" of molecules in patients' blood.

After spinal cord injury or stroke, axons originating in the brain's cortex and along the spinal cord become damaged, disrupting motor skills. Now, according to new findings published today in Neuron, a team of scientists at Boston Children's Hospital has developed a method to promote axon regrowth after injury.

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information - like patients suffering from neuropsychiatric disorders.

University at Buffalo researchers have developed and successfully tested a method for determining how relevant to the human disease findings are from mouse models. The research was published Aug. 8 in Stem Cell Reports.

Here we explore how the development of cancer immunotherapies has started to focus on improving efficiency, safety, and specificity by using genetic engineering approaches.